CROMPTON & KNOWLES CORP
10-Q, 1996-08-12
INDUSTRIAL ORGANIC CHEMICALS
Previous: CRAWFORD & CO, 10-Q, 1996-08-12
Next: DATA DIMENSIONS INC, 10-Q, 1996-08-12





                SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C.  20549


                             FORM 10-Q


(Mark One)
X     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
      SECURITIES  EXCHANGE ACT OF 1934  for the quarterly period
      ended June 29, 1996

                                  OR

      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
      SECURITIES EXCHANGE ACT OF 1934  for the transition period
      from              to                 

                       Commission File No. 1-4663

                     Crompton & Knowles Corporation
           (exact name of registrant as specified in its charter)


     Massachusetts                            04-1218720   
     (State or other jurisdiction of          (I.R.S. Employer
     incorporation or organization)           Identification No.)

     One Station Place, Metro Center
     Stamford, Connecticut                    06902   
     (address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (203)353-5400



     Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.                                
                                                 Yes   X  No     

     Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.

         Class                    Outstanding at July 17, 1996
Common Stock, $.10 par value             48,039,309 shares


                                                                 



                 CROMPTON & KNOWLES CORPORATION
                           FORM 10-Q 
                FOR QUARTER ENDED JUNE 29, 1996



                             INDEX




 PART I.     FINANCIAL INFORMATION:

 Item 1.     Condensed Financial Statements and
             Accompanying Notes

             .  Consolidated Statements of Earnings
                (unaudited) - Quarters and six months
                 ended June 29, 1996 and July 1, 1995

             .  Consolidated Balance Sheets - June 29, 1996
                (unaudited) and December 30, 1995

             .  Consolidated Statements of Cash Flows
                (unaudited) - Six months ended
                 June 29, 1996 and July 1, 1995

             .  Notes to the Consolidated Financial
                Statements - Quarter ended June 29, 1996
                (unaudited)


 Item 2.     Management's Discussion and Analysis of Financial
             Condition and Results of Operations

 

 PART II.    OTHER INFORMATION:

 Item 1.     Legal Proceedings

 Item 5.     Other Information

 Item 6.     Exhibits and Reports on Form 8-K

 Signatures

  Exhibit 11  Statement Re Computation of Per Share Earnings

 *Exhibit 27  Financial Data Schedule 
 


* A copy of this Exhibit is annexed to this report on Form 10-Q
provided to the Securities and Exchange Commission and the New
York Stock Exchange.





                                



                                                                   UNAUDITED
CROMPTON & KNOWLES CORPORATION AND SUBSIDIARIES
Consolidated Statements of Earnings
Quarters and six months ended June 29, 1996 and July 1, 1995
(In thousands, except per share data)

                                    Quarters ended         Six months ended
                                  June 29,   July 1,     June 29,   July 1,
                                  1996       1995        1996       1995


 Net sales                        $ 167,570  $ 175,617   $ 332,410  $ 343,810


 Cost of products sold              118,854    123,799     235,802    240,358

 Selling, general and administrative 27,564     26,736      54,658     52,158

 Depreciation and amortization        4,117      3,769       8,126      7,494

 Interest                             2,293      2,034       4,330      3,602

 Other income                          (199)       (13)       (451)      (241)

   Total costs and expenses         152,629    156,325     302,465    303,371


 Earnings before income taxes        14,941     19,292      29,945     40,439

 Income taxes                         5,229      7,234      10,765     15,185


 Net earnings                     $   9,712  $  12,058   $  19,180  $  25,254


 Net earnings per common share    $    .20   $    .25    $    .40   $    .52 


 Dividends per common share       $   .135   $   .135    $    .27   $   .255 


 Average shares outstanding          48,499     48,577      48,499     48,569









See accompanying notes to consolidated financial statements.
                                     




                                           June 29, 1996 UNAUDITED

CROMPTON & KNOWLES CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
June 29, 1996 and December 30, 1995
(In thousands of dollars)

                                         June 29,           December 30,
                                         1996               1995
 ASSETS
 CURRENT ASSETS
 Cash                                    $      3,869       $        918
 Accounts receivable                          128,173            112,693
 Inventories                                  170,147            154,846
 Other current assets                          29,070             23,038
     Total current assets                     331,259            291,495
 NON-CURRENT ASSETS
 Property, plant and equipment                134,204            129,991
 Cost in excess of acquired net assets         60,594             51,922
 Other assets                                  11,312             10,730
                                         $    537,369       $    484,138


 LIABILITIES AND STOCKHOLDERS' EQUITY
 CURRENT LIABILITIES
 Notes payable                           $     75,358       $     60,439
 Accounts payable                              58,913             49,415
 Accrued expenses                              39,212             35,136
 Income taxes payable                           6,050              3,747
 Other current liabilities                     21,089             16,578
     Total current liabilities                200,622            165,315
 NON-CURRENT LIABILITIES
 Long-term debt                                79,000             64,000
 Accrued postretirement liability               7,768              7,559
 Deferred income taxes                          7,170              7,217

 STOCKHOLDERS' EQUITY
 Common stock                                   5,336              5,336
 Additional paid-in capital                    59,567             59,440
 Retained earnings                            240,326            234,113
 Accumulated translation adjustment             2,301              6,320
 Treasury stock at cost                       (62,831)           (62,972)
 Deferred compensation                         (1,890)            (2,190)
     Total stockholders' equity               242,809            240,047

                                         $    537,369       $    484,138

See accompanying notes to consolidated financial statements.
                                                              UNAUDITED
CROMPTON & KNOWLES CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Six months ended June 29, 1996 and July 1, 1995
(In thousands of dollars)



                                                      June 29,     July 1,
Increase (decrease) to cash                             1996         1995
CASH FLOWS FROM OPERATING ACTIVITIES
  Net earnings                                      $  19,180    $  25,254
  Adjustments to reconcile net earnings
    to net cash provided by operations:
  Depreciation and amortization                         8,126        7,494
  Deferred compensation                                   300          383
  Changes in assets and liabilities, net              (18,638)     (29,845)
    Net cash provided by operations                     8,968        3,286

CASH FLOWS FROM INVESTING ACTIVITIES
  Acquisitions                                        (15,713)      (8,633)
  Capital expenditures                                 (6,209)     (10,037)
  Other investing activities                             (954)        (584)
    Net cash used by investing activities             (22,876)     (19,254)

CASH FLOWS FROM FINANCING ACTIVITIES
  Proceeds from long-term borrowings                   15,000           - 
  Change in notes payable                              15,074       33,329
  Net treasury stock activity                             104       (3,395)
  Dividends paid                                      (12,967)     (12,361)
    Net cash provided by financing activities          17,211       17,573

CASH
  Effect of exchange rates on cash                       (352)         110
  Change in cash                                        2,951        1,715
  Cash at beginning of period                             918        1,832
  Cash at end of period                             $   3,869    $   3,547














See accompanying notes to consolidated financial statements.




CROMPTON & KNOWLES CORPORATION AND SUBSIDIARIES
Notes to the Consolidated Financial Statements
Quarter ended June 29, 1996 (Unaudited)
(In thousands)


PRESENTATION OF CONSOLIDATED FINANCIAL STATEMENTS

The information included in the foregoing consolidated financial
statements is unaudited but reflects all adjustments (consisting
only of normal recurring adjustments) which are, in the opinion
of management, necessary for a fair statement of the results for
the interim periods presented.  

Included in accounts receivable are allowances for doubtful
accounts of $3,017 in 1996 and $3,269 at December 30, 1995.

Accumulated depreciation amounted to $105,527 in 1996 and $99,292
at December 30, 1995.

Accumulated amortization of cost in excess of acquired net assets
amounted to $9,044 in 1996 and $8,281 at December 30, 1995.  

Other current liabilities primarily include customer deposits.

It is suggested that the interim consolidated financial
statements be read in conjunction with the consolidated financial
statements and notes included in the Company's 1995 Annual Report
on Form 10-K.


CAPITAL STOCK

There are 53,361,072 common shares issued at $.10 par value, of
which 5,321,763 shares and 5,351,962 shares were held in the
treasury at June 29, 1996 and December 30, 1995, respectively.


INVENTORIES 

Components of inventories are as follows:
                                    June 29,        Dec. 30, 
                                     1996            1995   

Finished goods                     $ 96,213        $ 89,177 
Work in process                      37,993          30,316 
Raw materials and supplies           35,941          35,353 

                                   $170,147        $154,846 

EARNINGS PER COMMON SHARE

The computation of earnings per common share is based on the
weighted average number of common and common equivalent shares
outstanding.  A dual presentation of earnings per common share
has not been made since there is no significant difference in
earnings per share calculated on a primary or fully diluted
basis.


ACQUISITIONS

In January 1996, the Company acquired ER-WE-PA, GMBH at a cost of
$10,025 subject to audit adjustment.  In April 1996, the Company
acquired the Hartig line of industrial blow molding systems at a
cost of $5,688.  The acquisitions have been accounted for using
the purchase method and, accordingly, the acquired assets and
liabilities have been recorded at their fair values at the dates
of acquisition.  The excess cost of the purchase price over fair
value of net assets acquired in the amount of $9,142 is being
amortized over forty years.  The operating results of each
acquisition are included in the consolidated statements of
earnings since the date of acquisition.



BUSINESS SEGMENT DATA
                                         Quarter Ended
                                    June 29,         July 1,      
                                     1996             1995 

SALES
Specialty chemicals                $ 96,935        $101,229
Specialty process equipment
    and controls                     70,635          74,388

                                   $167,570        $175,617

OPERATING PROFIT  
Specialty chemicals                $ 13,039        $ 13,133
Specialty process equipment
    and controls                      6,395          11,043
General corporate expense           ( 2,399)        ( 2,863)
Operating profit                     17,035          21,313
Interest expense                    ( 2,293)        ( 2,034)
Other income                            199              13

Earnings before income taxes       $ 14,941        $ 19,292

                                         Six Months Ended
                                    June 29,         July 1,      
                                     1996             1995 

SALES
Specialty chemicals                $193,018        $203,771
Specialty process equipment
    and controls                    139,392         140,039
                                   $332,410        $343,810

OPERATING PROFIT  
Specialty chemicals                $ 25,830        $ 28,724
Specialty process equipment
    and controls                     13,501          21,100
General corporate expense           ( 5,507)        ( 6,024)
Operating profit                     33,824          43,800
Interest expense                    ( 4,330)        ( 3,602)
Other income                            451             241

Earnings before income taxes       $ 29,945        $ 40,439



Recent Event

Pursuant to an Agreement and Plan of Merger, dated as of April
30, 1996 (the "Merger Agreement"), Crompton has agreed to the
merger (the "Merger") of Tiger Merger Corp., a Delaware
corporation and a wholly owned subsidiary of Crompton
("Subcorp"), with and into Uniroyal Chemical Corporation, a
Delaware corporation ("Uniroyal"), subject to the approval of the
transaction by the stockholders of each of Uniroyal and Crompton
at special meetings thereof currently scheduled to be held on
August 21, 1996.  The Board of Directors of Crompton has fixed
the close of business on July 9, 1996, as the record date for
determination of holders of Crompton Common Stock entitled to
notice of and to vote at such meeting of Crompton stockholders.

The Merger will be accounted for on a pooling-of-interests basis
and will be consummated on the terms and subject to the
conditions set forth in the Merger Agreement (which was filed by
Crompton with the Commission as an exhibit to Crompton's
Quarterly Report on Form 10-Q for the quarter ended March 30,
1996), pursuant to which, among other things, (i) Subcorp will be
merged with and into Uniroyal as a result of which Uniroyal will
become a wholly owned subsidiary of Crompton, (ii) each issued
and outstanding share (other than shares, if any, held in the
treasury of Uniroyal or held by Crompton or any of its
subsidiaries, which will be canceled) of common stock, $0.01 par
value per share (together with the attached preferred stock
purchase rights, "Uniroyal Common Stock"), of Uniroyal will be
converted into 0.9577 shares of Crompton Common Stock (with cash
in lieu of fractional shares), and (iii) each issued and
outstanding share (other than shares, if any, held in the
treasury of Uniroyal or held by Crompton or any of its
subsidiaries, which will be canceled, and other than shares as to
which dissenters' appraisal rights have been perfected) of Series
A Cumulative Redeemable Preferred Stock, par value $0.01 per
share ("Series A Preferred Stock"), of Uniroyal and of Series B
Preferred Stock, par value $0.01 per share ("Series B Preferred
Stock," and together with the Series A Preferred Stock, "Uniroyal
Preferred Stock"), of Uniroyal will be converted into 6.3850
shares of Crompton Common Stock (with cash in lieu of fractional
shares).  It is currently anticipated that the Merger will be
consummated shortly after the special meetings of Crompton and
Uniroyal stockholders, assuming the Merger Agreement and the
Merger are approved at such meetings and all other conditions of
the Merger have been satisfied or waived.

Crompton, Uniroyal and the Directors of Uniroyal were named as
defendants in a purported class action lawsuit (the "Stockholder
Action") filed in connection with the proposed Merger in the
Court of Chancery, County of New Castle, State of Delaware. 
Fassbender v. Mazaika, C.A. No. 14980.  The Stockholder Action
alleged, among other things, that defendant directors breached
their fiduciary duties by pursuing the Merger at an allegedly
unfair and inadequate price; by agreeing to the proposed Merger
without having conducted an "auction process or active market
check" or a full and thorough investigation; and by agreeing to
the allegedly unfair terms of the Merger.  The Stockholder Action
was brought on behalf of a purported class of persons consisting
of the stockholders of Uniroyal other than defendants.

Counsel for Uniroyal, Crompton and Subcorp and the counsel for
plaintiff entered into a memorandum of understanding (the
"Memorandum of Understanding") dated August 5, 1996 in connection
with the settlement of the Stockholder Action.  Among other
things, the Memorandum of Understanding provides that, in full
settlement of the claims asserted, (i) the Merger Agreement be
amended so as to reduce the fee payable to Crompton upon
termination of the Merger Agreement under certain circumstances
from $50 million to $35 million, (ii) Uniroyal promptly disseminate to
Uniroyal stockholders its third quarter results, (iii) the
defendants publicly disclose the proposed settlement by a filing
with the Commission and (iv) the plaintiff withdraw his request
for a preliminary injunction enjoining consummation of the
Merger.  The Merger Agreement was amended as of August 7, 1996 to
reduce the termination fee as contemplated in the Memorandum of
Understanding.

The consummation of the proposed settlement is subject to (i)
completion by the plaintiff of discovery, (ii) execution of
definitive settlement documents, (iii) notice to members of the
plaintiff class and (iv) approval by the Delaware Court of
Chancery.  In connection with the proposed settlement, the
defendants have agreed that they will not oppose plaintiff's
counsel's application for an award of fees and expenses not to
exceed $350,000 in the aggregate, to be paid by Crompton and/or
Uniroyal.

Uniroyal and its directors have denied, and continue to deny,
that any of them have committed any violations of law or breaches
of duty to plaintiff or any member of the plaintiff class,
Uniroyal or its stockholders, or anyone else.  The defendants
entered into the Memorandum of Understanding in order to
eliminate the distraction and expense of further litigation.
           
 
 
             MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
 
 
 
 SECOND QUARTER RESULTS
 
 Overview
 
 Consolidated net sales of $167.6 million for the second quarter
 of 1996 declined 5% from the comparable 1995 period.  Net
 earnings of $9.7 million declined 19% versus the second quarter
 of 1995.  Net earnings per common share of $.20 were 20% lower
 than the $.25 reported last year.
 
 Gross margin as a percentage of net sales decreased to 29.1%
 from 29.5% in the second quarter of 1995 primarily as a result
 of lower margins in the specialty process equipment and controls
 segment.  Consolidated operating profit of $17.0 million
 declined 20% from the second quarter of 1995 as the specialty
 chemicals segment approximated the prior years quarter and the
 specialty process equipment and controls segment decreased 42%.
 
 Specialty Chemicals
 
 The Company's specialty chemicals segment reported sales of
 $96.9 million which represents a decline of 4% from the second
 quarter of 1995.  The decrease was attributable to the impact of 
 lower selling prices (-3%) and lower unit volume (-1%).
 
 Domestic dyes sales of $46.9 million declined 5% from the
 comparable 1995 quarter due to lower selling prices (-4%) and
 lower unit volume (-1%).  International dyes sales of $23.6
 million declined 12% versus the second quarter of 1995 primarily
 as a result of lower selling prices (-4%) and the balance
 primarily from lower unit volume under a long-term supply
 agreement. Specialty ingredients sales of $26.5 million rose 7%
 primarily as a result of increased unit volume.  The percentage
 of sales outside the United States was 26%, versus 28% in the
 comparable 1995 period.
 
 Operating profit of $13.0 million approximated the $13.1 million
 reported in the second quarter of 1995. The percentage of
 operating profit outside the United States increased to 20% from
 15% in the comparable quarter in 1995. 
 
 
 
 
 
 Specialty Process Equipment and Controls 
 
 The Company's specialty process equipment and controls segment
 reported sales of $70.7 million, which represents a decrease of
 5% from the second quarter of 1995. The decrease was
 attributable primarily to lower unit volume in the domestic
 business (as lower demand for U.S. extrusion equipment
 continued) more than offsetting a 23% increase from acquisitions
 (primarily ER-WE-PA).  Export sales shipped from the U.S.
 accounted for 16% of total segment sales versus 19% in the
 comparable period in 1995. International sales increased as a
 result of the ER-WE-PA acquisition and accounted for 24% of
 total segment sales versus 6% in the second quarter 1995.
 
 Operating profit for the second quarter of 1996 declined 42% to
 $6.4 million primarily attributable to lower unit volume in the
 higher margin domestic business.  International operating profit
 was not significant in either the second quarter of 1996 or
 1995.  The order backlog for extruders and related equipment at
 the end of the second quarter of 1996 amounted to $89 million
 (including ER-WE-PA backlog of $16 million) compared to $72
 million at December 30, 1995.
 
 Other
 
 Selling, general and administrative expenses of $27.6 million
 increased 3% versus the comparable period in 1995 primarily due
 to the impact of acquisitions.  Depreciation and amortization of
 $4.1 million increased 9% versus 1995 primarily as a result of a
 higher fixed asset base including acquisitions.  Interest
 expense increased $259 thousand primarily as a result of
 increased borrowings.  Other income increased $186 thousand
 versus the second quarter of 1995.  The effective tax rate of
 35.0% decreased from the 37.5% in the comparable 1995 period.
 
 
 YEAR-TO-DATE RESULTS
 
 Overview
 
 Consolidated net sales of $332.4 million for the first six
 months of 1996 decreased 3% from the comparable period in 1995. 
 Net earnings of $19.2 million decreased 24% versus the $25.3
 million earned in the first half of 1995.  Net earnings per
 common share of $.40 decreased 23% from the $.52 reported last
 year.
 
 Gross margin as a percentage of net sales decreased to 29.1%
 from 30.1% in the comparable 1995 period primarily as a result 
 of lower margins in the specialty process equipment and controls
 segment.  Consolidated operating profit of $33.8 million
 declined 23% from $43.8 million in the first half of 1995 as
 specialty chemicals decreased 10% and specialty process
 equipment and controls decreased 36%.
 
 Specialty Chemicals
 
 The Company's specialty chemicals segment reported sales of
 $193.0 million representing a 5% decrease from $203.8 million 
 in the first six months of 1995.  The decrease was primarily
 attributable to the impact of lower unit volume (-3%) and lower
 selling prices (-2%).
 
 Domestic dyes sales of $93.5 million were 8% lower than the
 first six months of 1995 primarily due to lower unit volume
 (-5%) and lower selling prices (-3%).  International dyes sales
 of $47.0 million decreased by 9% versus 1995 primarily as an
 equal result of lower selling prices and lower unit volume. 
 Specialty ingredients sales rose 4% to $52.5 million reflecting
 primarily increased unit volume.  The percentage of sales
 outside the United States decreased slightly to 26% from 27% for
 the comparable period in 1995.
 
 Operating profit of $25.8 million for the first six months of
 1996 decreased 10% from 1995.  The decrease was attributable
 primarily to the impact of lower pricing in the domestic dyes
 business.  The percentage of operating profit outside the United
 States remained the same at 16% from year to year.
 
 Specialty Process Equipment and Controls
 
 The Company's specialty process equipment and controls segment
 reported sales of $139.4 million versus $140.0 million for the
 first six months of 1995.  The slight decline was comprised of a
 22% increase attributable to the incremental impact of
 acquisitions offset primarily by lower unit volume in the
 domestic business.  Export sales shipped from the U.S. accounted
 for 22% of total segment sales versus 19% in the comparable
 period in 1995.  International sales of $28.2 million increased
 from $4.7 million in 1995 primarily as a result of the ER-WE-PA
 acquisition and accounted for 20% of total segment sales versus
 3% in the first six months of 1995.
 
 Operating profit of $13.5 million decreased 36% versus the
 comparable 1995 period due primarily to the decline in unit
 volume in the higher margin domestic business.  International
 operating profit was not significant in either the first half of
 1996 or 1995.
 
 
 Other
 
 Selling, general and administrative expenses of $54.7 million
 increased 5% versus the first six months of 1995 primarily due
 to the impact of acquisitions.  Depreciation and amortization of
 $8.1 million increased 8% versus the 1995 period primarily as a
 result of a higher fixed capital base including acquisitions. 
 Interest expense of $4.3 million increased $728 thousand
 primarily as a result of increased borrowings.  Other income of
 $451 thousand increased $210 thousand versus 1995.  The
 effective tax rate of 36.0% decreased from the 37.6% in the
 comparable 1995 period.
 
 
 LIQUIDITY AND CAPITAL RESOURCES
 
 The June 29, 1996 working capital balance of $130.6 million
 increased $4.4 million from $126.2 million at year-end 1995. 
 The current ratio declined slightly to 1.7 from 1.8 at the end
 of 1995. Days sales in receivables averaged 63 days in the first
 half of 1996, versus 55 days for all of 1995, primarily as a
 result of longer collection periods in the specialty process
 equipment and controls business.  Inventory turnover averaged
 2.8 for the first half of 1996 unchanged from year-end 1995. 
 
 Cash flows from operating activities of $9.0 million increased
 $5.7 million from the first half of 1995 primarily attributable
 to decreases in working capital requirements partially offset by
 lower earnings.  Cash provided by operations and increased
 borrowings were used to finance acquisitions, fund capital
 expenditures and pay cash dividends.  The Company's debt to
 total capital ratio increased to 39% from 34% at year-end 1995. 
 Capital expenditures are expected to approximate $16 million in
 1996 primarily for expansion and improvement of operating
 facilities in the United States and Europe.  The Company's long-term
 liquidity needs including such items as capital
 expenditures and dividends are expected to be financed from
 operations.
 
 
 INTERNATIONAL OPERATIONS
 
 The stronger U.S. dollar exchange rate versus the Belgian Franc
 and French Franc accounted primarily for the reduction of $4.0
 million in the accumulated translation adjustment account since
 year-end 1995.  Changes in the balance of this account are
 primarily a function of fluctuations in exchange rates and do
 not necessarily reflect either enhancement or impairment of the
 net asset values or the earnings potential of the Company's
 foreign operations.
 
 The Company operates manufacturing facilities in Europe which
 serve primarily the European market.  Exchange rate disruptions
 between the United States and European currencies, and among
 European currencies, are not expected to have a material effect
 on year-to-year comparisons of the Company's earnings.
 
 
 RESEARCH AND DEVELOPMENT
 
 The Company employs about 285 engineers, draftsmen, chemists,
 and technicians responsible for developing new and improved
 chemical products and process equipment systems for the
 industries served by the Company.  Often, new products are
 developed in response to specific customer needs.  The Company's 
 process of developing and commercializing new products and
 product improvements is ongoing and involves many products, no
 one of which is large enough to significantly impact the
 Company's results of operations from year-to-year.  Research and
 development expenditures totaled $6.9 million for the first half
 of 1996 compared to $7.2 million in the comparable 1995 period.
 
 ENVIRONMENTAL MATTERS
 
 The Company's manufacturing facilities are subject to various
 federal, state and local requirements with respect to the
 discharge of materials into the environment or otherwise
 relating to the protection of the environment.  The Company has
 been designated, along with others, as a potentially responsible
 party under the Comprehensive Environmental Response,
 Compensation and Liability Act of 1980, or comparable state
 statutes, at two waste disposal sites; and an inactive
 subsidiary has been designated, along with others, as a
 potentially responsible party at two other sites.
 
 While the cost of compliance with existing environmental
 requirements is expected to increase, based on the facts
 currently known to the Company, management expects that those
 costs, including the cost to the Company of remedial actions at
 the waste disposal sites where it has been named a potentially
 responsible party, will not be material to the results of the
 Company's operations in any given year. 
 

PART II.  OTHER INFORMATION:


Item 1.  Legal Proceedings

     Crompton, Uniroyal and the Directors of Uniroyal were named
     as defendants in a purported class action lawsuit (the
     "Stockholder Action") filed in connection with the proposed
     Merger in the Court of Chancery, County of New Castle, State
     of Delaware.  Fassbender v. Mazaika, C.A. No. 14980.  The
     Stockholder Action alleged, among other things, that
     defendant directors breached their fiduciary duties by
     pursuing the Merger at an allegedly unfair and inadequate
     price; by agreeing to the proposed Merger without having
     conducted an "auction process or active market check" or a
     full and thorough investigation; and by agreeing to the
     allegedly unfair terms of the Merger.  The Stockholder
     Action was brought on behalf of a purported class of persons
     consisting of the stockholders of Uniroyal other than
     defendants.

     Counsel for Uniroyal, Crompton and Subcorp and the counsel
     for plaintiff entered into a memorandum of understanding
     (the "Memorandum of Understanding") dated August 5, 1996 in
     connection with the settlement of the Stockholder Action. 
     Among other things, the Memorandum of Understanding provides
     that, in full settlement of the claims asserted, (i) the
     Merger Agreement be amended so as to reduce the fee payable
     to Crompton upon termination of the Merger Agreement under
     certain circumstances from $50 million to $35 million, (ii)
     Uniroyal promptly disseminate to Uniroyal stockholders its
     third quarter results, (iii) the defendants publicly
     disclose the proposed settlement by a filing with the
     Commission and (iv) the plaintiff withdraw his request for a
     preliminary injunction enjoining consummation of the Merger.
     The Merger Agreement was amended as of August 7, 1996 to reduce
     the termination fee as contemplated in the Memorandum of 
     Understanding.

     The consummation of the proposed settlement is subject to
     (i) completion by the plaintiff of discovery, (ii) execution
     of definitive settlement documents, (iii) notice to members
     of the plaintiff class and (iv) approval by the Delaware
     Court of Chancery.  In connection with the proposed
     settlement, the defendants have agreed that they will not
     oppose plaintiff's counsel's application for an award of
     fees and expenses not to exceed $350,000 in the aggregate,
     to be paid by Crompton and/or Uniroyal.

     Uniroyal and its directors have denied, and continue to
     deny, that any of them have committed any violations of law
     or breaches of duty to plaintiff or any member of the
     plaintiff class, Uniroyal or its stockholders, or anyone
     else.  The defendants entered into the Memorandum of
     Understanding in order to eliminate the distraction and
     expense of further litigation.

Item 5.  Other Information

     Pursuant to an Agreement and Plan of Merger, dated as of
     April 30, 1996 (the "Merger Agreement"), Crompton has agreed
     to the merger (the "Merger") of Tiger Merger Corp., a
     Delaware corporation and a wholly owned subsidiary of
     Crompton ("Subcorp"), with and into Uniroyal Chemical
     Corporation, a Delaware corporation ("Uniroyal"), subject to
     the approval of the transaction by the stockholders of each
     of Uniroyal and Crompton at special meetings thereof
     currently scheduled to be held on August 21, 1996.  The
     Board of Directors of Crompton has fixed the close of
     business on July 9, 1996, as the record date for
     determination of holders of Crompton Common Stock entitled
     to notice of and to vote at such meeting of Crompton
     stockholders.

     The Merger will be accounted for on a pooling-of-interests
     basis and will be consummated on the terms and subject to
     the conditions set forth in the Merger Agreement (which was
     filed by Crompton with the Commission as an exhibit to
     Crompton's Quarterly Report on Form 10-Q for the quarter
     ended March 30, 1996), pursuant to which, among other
     things, (i) Subcorp will be merged with and into Uniroyal as
     a result of which Uniroyal will become a wholly owned
     subsidiary of Crompton, (ii) each issued and outstanding
     share (other than shares, if any, held in the treasury of
     Uniroyal or held by Crompton or any of its subsidiaries,
     which will be canceled) of common stock, $0.01 par value per
     share (together with the attached preferred stock purchase
     rights, "Uniroyal Common Stock"), of Uniroyal will be
     converted into 0.9577 shares of Crompton Common Stock (with
     cash in lieu of fractional shares), and (iii) each issued
     and outstanding share (other than shares, if any, held in
     the treasury of Uniroyal or held by Crompton or any of its
     subsidiaries, which will be canceled, and other than shares
     as to which dissenters' appraisal rights have been
     perfected) of Series A Cumulative Redeemable Preferred
     Stock, par value $0.01 per share ("Series A Preferred
     Stock"), of Uniroyal and of Series B Preferred Stock, par
     value $0.01 per share ("Series B Preferred Stock," and
     together with the Series A Preferred Stock, "Uniroyal
     Preferred Stock"), of Uniroyal will be converted into 6.3850
     shares of Crompton Common Stock (with cash in lieu of
     fractional shares).  It is currently anticipated that the
     Merger will be consummated shortly after the special
     meetings of Crompton and Uniroyal stockholders, assuming the
     Merger Agreement and the Merger are approved at such
     meetings and all other conditions of the Merger have been
     satisfied or waived.
Item 6.  Exhibits and Reports on Form 8-K

    (a)  Exhibits:
                                                                 
         Number              Description                         

         (11)      Statement Re Computation of 
                   Per Share Earnings

         (27)*     Financial Data Schedule

    (b)  No reports on Form 8-K were filed during the quarter
         for which this report is filed.





    * A copy of this Exhibit is annexed to this report on Form
10-Q provided to the Securities and Exchange Commission and the
New York Stock Exchange.

                           SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.




                                CROMPTON & KNOWLES CORPORATION
                                                  (Registrant)




August 12, 1996                By: /s/ Charles J. Marsden
                                   Charles J. Marsden
                                   Vice President-Finance and
                                   Chief Financial Officer 

August 12, 1996                By: /s/ John T. Ferguson II 
                                   John T. Ferguson II
                                   General Counsel and Secretary





CROMPTON & KNOWLES CORPORATION AND SUBSIDIARIES
EXHIBIT 11 - STATEMENT RE COMPUTATION OF PER SHARE EARNINGS
(In thousands, except per share data)




                    PRIMARY
                    Quarter Ended        Six Months Ended
                      June 29,  July 1,    June 29,  July 1,
                       1996      1995       1996      1995
Earnings

Net earnings        $  9,712  $ 12,058   $ 19,180  $ 25,254




Shares

Weighted average
 shares outstanding   48,033    48,034     48,026    48,031
Common stock
 equivalents             424       530        281       504

Average shares
 outstanding          48,457    48,564     48,307    48,535




Per share

Net earnings        $   0.20  $   0.25   $   0.40  $   0.52



                    FULLY DILUTED
                    Quarter Ended        Six Months Ended
                      June 29,  July 1,    June 29,  July 1,
                       1996      1995       1996      1995
Earnings

Net earnings        $  9,712  $ 12,058   $ 19,180  $ 25,254




Shares

Weighted average
 shares outstanding   48,033    48,034     48,026    48,031
Common stock
 equivalents             466       543        473       538

Average shares
 outstanding          48,499    48,577     48,499    48,569




Per share

Net earnings        $   0.20  $   0.25   $   0.40  $   0.52





<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-28-1996
<PERIOD-END>                               JUN-29-1996
<CASH>                                           3,869
<SECURITIES>                                         0
<RECEIVABLES>                                  128,173
<ALLOWANCES>                                     3,017
<INVENTORY>                                    170,147
<CURRENT-ASSETS>                               331,259
<PP&E>                                         134,204
<DEPRECIATION>                                 105,527
<TOTAL-ASSETS>                                 537,369
<CURRENT-LIABILITIES>                          200,622
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         5,336
<OTHER-SE>                                     237,473
<TOTAL-LIABILITY-AND-EQUITY>                   537,369
<SALES>                                        332,410
<TOTAL-REVENUES>                               332,410
<CGS>                                          235,802
<TOTAL-COSTS>                                  298,586
<OTHER-EXPENSES>                                 (451)
<LOSS-PROVISION>                                 (374)
<INTEREST-EXPENSE>                               4,330
<INCOME-PRETAX>                                 29,945
<INCOME-TAX>                                    10,765
<INCOME-CONTINUING>                             19,180
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    19,180
<EPS-PRIMARY>                                     0.40
<EPS-DILUTED>                                     0.40
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission